Possible mechanism of miltefosine-mediated death of Leishmania donovani

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 8, 2004, Pages 3010-3015

  Verma, Navin K ^a   Dey, Chinmoy S ^a,b  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^b SAS Nagar   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS DNA; DNA FRAGMENT; MILTEFOSINE;

AMASTIGOTE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; IN VITRO STUDY; LEISHMANIA DONOVANI; NICK END LABELING; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; PROMASTIGOTE;

ANIMALS; ANTIPROTOZOAL AGENTS; APOPTOSIS; CELL DIVISION; COLORING AGENTS; CRICETINAE; CRICETULUS; DNA FRAGMENTATION; DNA, PROTOZOAN; IN SITU NICK-END LABELING; INDICATORS AND REAGENTS; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MACROPHAGES; NUCLEOSOMES; PHOSPHORYLCHOLINE; POLY(ADP-RIBOSE) POLYMERASES; PROPIDIUM; TETRAZOLIUM SALTS; THIAZOLES;

EID: 3342943546     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.8.3010-3015.2004     Document Type: Article

References (61)

1. Ameisen, J. C. 1996. The origin of programmed cell death. Science 272:1278-1279.
2. Arnoult, D., K. Akarid, A. Grodet, P. X. Petit, J. Estaquier, and J. C. Ameisen. 2002. On the evaluation of programmed cell death: apoptosis of the unicellular eukaryote Leishmania major involves cysteine proteinase activation and mitochondrion permeabilization. Cell Death Differ. 9:65-81.
3. Arvind, L., V. M. Dixit, and E. V. Konin. 2001. Apoptotic molecular machinery: vastly increased complexity in vertebrates revealed by genome comparisons. Science 291:1279-1284.
4. Balanco, J. M. F., M. E. C. Moreira, A. Bonomo, P. T. Bozza, G. A. Mendes, C. Pirmez, and M. A. Barcinski. 2001. Apoptotic mimicry by an obligate intracellular parasite downregulates macrophage microbial activity. Curr. Biol. 11:1870-1873.
5. Basselin, M., F. Lawrence, and M. Robert-Gero. 1996. Pentamidine uptake in Leishmania donovani and Leishmania amazonensis, promastigotes and amastigotes. Biochem. J. 315:631-634.
6. Berkovic, D., E. A. M. Fleer, H. Eibl, and C. Unger. 1992. Effects of hexadecylphosphocholine on cellular function. Prog. Exp. Tumor Res. 34:59-68.
7. Chaudhuri, G., A. Mukhopadhyay, and S. K. Basu. 1989. Selective delivery of drugs to macrophages through a highly specific receptor. Biochem. Pharmacol. 38:2995-3002.
8. Croft, S., L. D. Snowdon, and V. Yardly. 1996. The activities of four anti-cancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei. J. Antimicrob. Chemother. 38:1041-1047.
9. Croft, S. L., K. Seifert, and M. Duchene. 2003. Antiprotozoal activities of phospholipid analogues. Mol. Biochem. Parasitol. 126:165-172.
10. Das, M., S. B. Mukherjee, and C. Shaha. 2001. Hydrogen peroxide induces apoptosis-like death in Leishmania donovani promastigotes. J. Cell Sci. 114:2461-2469.
11. Debrabant, A., N. Lee, S. Bertholet, R. Duncan, and H. L. Nakhasi. 2003. Programmed cell death in trypanosomatids and other unicellular organisms. Int. J. Parasitol. 33:257-267.
12. DosReis, G. A., and M. A. Barcinski. 2001. Apoptosis and parasitism: from the parasite to the host immune response. Adv. Parasitol. 49:133-161.
13. Engelmann, J., J. Henke, and W. Willker. 1996. Early stage monitoring of miltefosine induced apoptosis in KB cells by multinuclear NMR spectroscopy. Anticancer Res. 16:1429-1440.
14. Ephros, M., A. Bitnun, P. Shaked, E. Waldman, and D. Zilbersten. 1999. Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes. Antimicrob. Agents Chemother. 43:278-282.
15. 3 (eldefosine) and amphotericin B. Acta Trop. 81:151-157.
16. Ganguly, N. K. 2002. Oral miltefosine may revolutionize treatment of visceral leishmaniasis. TDR News W. H. O. 68:2.
17. Haase, R., T. Wieder, C. C. Geilen, and W. Reutter. 1991. The phospholipid analogue hexadecylphosphocholine inhibits phosphocholine biosynthesis in Madin-Darby canine kidney cells. FEBS Lett. 288:129-132.
18. Hart, D. T., K. Vickerman, and G. H. Coombs. 1981. A quick, simple method for purifying Leishmania mexicana amastigotes in large numbers. Parasitology 82:345-355.
19. Heesbeen, E. C., L. F. Verdonck, G. E. Staal, and G. Rijksen. 1994. Protein kinase C is not involved in the cytotoxic action of 1-octadecyl-2-o- methyl-sn-glycerol-3-phosphocholine in HL-60 and K562 cells. Biochem. Pharmacol. 47:1481-1488.
20. Herwaldt, B. L. 1999. Miltefosine: the long awaited therapy for visceral leishmaniasis? N. Engl. J. Med. 341:1840-1842.
21. Hilgard, P., T. Klenner, J. Stekar, and C. Unger. 1993. Alkylphosphocholines: a new class of membrane active anticancer agents. Cancer Chemother. Pharmacol. 32:90-95.
22. Holzmuller, P., D. Sereno, M. Cavaleyra, L. Mangot, S. Daulouede, P. Vincendeau, and J. L. Lemesre. 2002. Nitric oxide-mediated proteosome-dependent oligonucleosomal DNA fragmentation in Leishmania amazonensis. Infect. Immun. 70:3727-3735.
23. Jayanarayan, K. G., and C. S. Dey. 2002. Resistance to arsenite modulates expression of β- and γ-tubulin and sensitivity to paclitaxal daring differentiation of Leishmania donovani. Parasitol. Res. 88:754-759.
24. Jayanarayan, K. G., and C. S. Dey. 2003. Overexpression and DNA topoisomerase II-like enzyme activity in arsenite resistant Leishmania donovani. Microbiol. Res. 158:55-58.
25. Jha, T. K., S. Sunder, C. P. Thakur, P. Bachmann, J. Karbwang, C. Fischer, A. Voss, and J. Berman. 1999. Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis. N. Engl. J. Med. 341:1795-1800.
26. Joshi, M., D. M. Dwyer, and H. L. Nakhasi. 1993. Cloning and characterization of expressed genes from in vitro grown amastigotes of Leishmania donovani. Mol. Biochem. Parasitol. 58:345-354.
27. Kaur, J., and C. S. Dey. 2000. Putative P-glycoprotein expression in arsenite resistant Leishmania donovani down regulated by verapamil. Biochem. Biophys. Res. Commun. 271:615-619.
28. Konstantinov, S. M., H. Eibl, and M. R. Berger. 1998. Alkylphosphocholines induce apoptosis in HL-60 and U-937 leukemic cells. Cancer Chemother. Pharmacol. 41:210-216.
29. Lazebnik, Y. A., S. H. Kaufmann, S. Desnoyers, C. G. Poirier, and W. C. Earnshaw. 1994. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371:346-347.
30. Lee, N., S. Bertholet, A. Debrabant, J. Mullar, R. Duncan, and H. L. Nakhasi. 2002. Programmed cell death in the unicellular protozoan parasite Leishmania. Cell Death Differ. 9:53-64.
31. Le Fichoux, Y., D. Rousseau, B. Ferrua, S. Ruette, A. Lelievre, D. Grousson, and J. Kubar. 1998. Short- and long-term efficacy of hexadecylphosphocholine against established Leishmania infantum infection in BALB/c mice. Antimicrob. Agents Chemother. 42:654-658.
32. Leonard, R., J. Hardy, G. van Tienhoven, S. Houston, P. Simmonds, M. David, and J. Mansi. 2001. Randomized, double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer. J. Clin. Oncol. 19:4150-4159.
33. Lux, H., D. T. Hart, P. J. Parker, and T. Klenner. 1996. Ether lipid metabolism, GPI anchor biosynthesis, and signal transduction are putative targets for antileishmanial alkyl phospholipids analogues. Adv. Exp. Med. Biol. 416:201-211.
34. Lux, H., N. Heise, T. Klenner, D. Hart, and F. R. Opperdoes. 2000. Ether-lipid (alkyl-phspholipid) metabolism and the mechanism of action of ether-lipid analogues in Leishmania. Mol. Biochem. Parasitol. 111:1-14.
35. Matsuyama, S., and J. C. Reed. 2000. Mitochondria-dependent apoptosis and cellular pH regulation. Cell Death Differ. 7:1155-1165.
36. Moreira, M. E. C., H. A. D. Portillo, R. V. Milder, J. M. F. Balanco, and M. A. Barcinski. 1996. Heat shock induction of apoptosis in promastigotes of the unicellular organism Leishmania (Leishmania) amazonensis. J. Cell Physiol. 167:305-313.
37. Paris, C., P. M. Loiseau, C. Bories, and J. Breard. 2004. Miltefosine induces apoptosis-like death in Leishmania donovani promastigotes. Antimicrob. Agents Chemother. 48:852-859.
38. Pearson, R. D. 2003. Development status of miltefosine as first oral drug in visceral and cutaneous leishmaniasis. Curr. Infect. Dis. Rep. 5:41-42.
39. Perez-Victoria, F. J., S. Castanysand, and F. Gamarro. 2003. Leishmania donovani resistant to miltefosine involves a defective inward translocation of the drug. Antimicrob. Agents Chemother. 47:2397-2403.
40. Prasad, V., J. Kaur, and C. S. Dey. 2000. Arsenite resistant Leishmania donovani promastigotes express an enhanced membrane P-type adenosine triphosphatase activity that is sensitive to verapamil treatment. Parasitol. Res. 86:661-664.
41. Prasad, V., S. S. Kumar, and C. S. Dey. 2000. Resistant to arsenite modulates levels of α-tubulin and sensitivity to paclitaxal in Leishmania donovani. Parasitol. Res. 86:838-842.
42. Prasad, V., and C. S. Dey. 2000. Tubulin is hyperphosphorylated on serine and tyrosine residues in Leishmania donovani promastigotes. Parasitol. Res. 86:876-880.
43. Ruiter, G. A., S. F. Zerp, H. Bartelink, W. J. Van Blitterswijk, and M. Verheij. 2003. Anti-cancer alkyl-lysopholipids inhibits the phosphatidylinositol 3-kinase-Akt/PKB survival pathway. Anticancer Drugs 14:167-173.
44. Rybczynska, M., M. Spitaler, N. G. Knebel, G. Boeck, H. Grunicke, and J. Hofmann. 2001. Effect of miltefosine on various biochemical parameters in a panel of tumor cell lines with different sensitivities. Biochem. Pharmacol. 62:765-772.
45. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed., vol. I-IlI. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
46. Saraiva, V. B., D. Gibaldi, J. O. Previato, L. M. Previato, M. T. Bozza, C. G. Freire-de-Lima, and N. Heise. 2002. Proinflammatory and cytotoxic effects of hexadecylphosphocholine (miltefosine) against drug-resistant strains of Trypanosama cruzi. Antimicrob. Agents Chemother. 46:3472-3477.
47. Schmidt-Ott, R., T. Klenner, P. Overath, and T. Aebischer. 1999. Topical treatment with hexadecylphosphocholine (Miltex) efficiently reduces parasite burden in experimental cutaneous leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 93:85-90.
48. Seifert, K., S. Matu, F. Javier Perez-Victoria, S. Castanys, F. Gamarro, and S. L. Croft. 2003. Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine). Int. J. Antimicrob. Agents 22:380-387.
49. Sereno, D., P. Holzmuller, I. Mangot, G. Cuny, A. Ouaissi, and J. L. Lemesre. 2001. Antimonial-mediated DNA fragmentation in Leishmania infantum amastigotes. Antimicrob. Agents Chemother. 45:2064-2069.
50. Soto, J., J. Toledo, P. Gutierez, R. S. Nicholls, J. Padila, J. Engel, C. Fischer, A. Voss, and J. Berman. 2001. Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent. Clin. Infect. Dis. 33:E57-E61.
51. Sperandio, S., L. de Belle, and D. E. Bredesen. 2000. An alternative non-apoptotic form of programmed cell death. Proc. Natl. Acad. Sci. USA 97:14376-14381.
52. Sundar, S., F. Rosenkaimer, M. K. Makharia, A. K. Goyel, A. K. Mandal, A. Voss, P. Hilgard, and H. W. Murray. 1998. Trial of oral miltefosine for visceral leishmaniasis. Lancet 352:1821-1823.
53. Sundar, S., L. B. Gupta, M. K. Makharia, M. K. Singh, A. Voss, F. Resenkaimer, J. Engel, and H. W. Murray. 1999. Oral treatment of visceral leishmaniasis with miltefosine. Ann. Trop. Med. Parasitol. 93:589-597.
54. Sundar, S., A. Makharia, D. K. More, G. Agrawal, A. Voss, C. Fischer, P. Bachmann, and H. W. Murray. 2000. Short-course of oral miltefosine for treatment of visceral leishmaniasis. Clin. Infect. Dis. 31:1110-1113.
55. Sundar, S., T. K. Jha, C. P. Thakur, J. Engel, H. Sindermann, C. Fischer, K. Junge, A. Bryceson, and J. Bermam. 2002. Oral miltefosine for Indian visceral leishmaniasis. N. Engl. J. Med. 347:1739-1746.
56. Uberall, F., H. Oberhuber, K. Maly, J. Zaknum, L. Demuth, and H. H. Grunicke. 1991. Hexadecylphosphocholine inhibitsinositol phosphate formation and protein kinase C activity. Cancer Res. 51:807-812.
57. Virag, L., and C. Szabo. 2002. The therapeutic potential of poly (ADPribose) polymerase inhibitors. Pharmacol. Rev. 54:375-429.
58. Welburn, S. C., and I. Maudlin. 1997. Control of Trypanosoma brucei brucei infections in tsetse, Glossina morsitans. Med. Vet. Entomol. 11:286-289.
59. Welburn, S. C., M. A. Barcinski, and G. T. Williams. 1999. Programmed cell death in Trypanosomatids. Parasitol. Today 13:22-26.
60. Wieder, T., W. Reutter, C. E. Orfanos, and C. C. Geilen. 1999. Mechanism of action of phospholipid analogs as anticancer compounds. Prog. Lipid Res. 38:249-259.
61. Zangger, H., J. C. Mottram, and N. Fasel. 2002. Cell death in Leishmania induced by stress and differentiation: programmed cell death or necrosis? Cell Death Differ. 9:1126-1139.